Developing technology to better understand environmental factors affecting Alzheimer's disease in underserved communities.

SBIR TOPIC 010 - TECHNOLOGY TO FACILITATE CHARACTERIZATION OF THE EXPOSOME IN UNDER-RESOURCED POPULATIONS FOR AD/ADRD STUDIES

NIH-funded research Seabright LLC · NIH-11217854

This study is looking at how different environmental factors might affect the development of Alzheimer's disease and related conditions, especially in communities that often don't get enough support, and it invites patients to share information about their surroundings and health to help improve understanding and treatment of these diseases.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSeabright LLC NIH-funded
Lab location1 site (Seattle, United States)
Project IDNIH-11217854 on NIH RePORTER

What this research studies

This research focuses on creating innovative technology to characterize the exposome, which includes all environmental exposures that may influence the development of Alzheimer's disease and related dementias (AD/ADRD). By targeting under-resourced populations, the project aims to gather data that can help identify how various factors contribute to these conditions. Patients may be involved in providing information about their environments and health, which will be analyzed to improve understanding and treatment of Alzheimer's disease. The methodology includes collecting and analyzing data from diverse populations to ensure comprehensive insights.

Who could benefit from this research

Good fit: Ideal candidates for participation are individuals from under-resourced populations who are at risk for or diagnosed with Alzheimer's disease or related dementias.

Not a fit: Patients who do not have Alzheimer's disease or related dementias, or those not from under-resourced populations, may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for Alzheimer's disease, particularly in underserved communities.

How similar studies have performed: While the approach of characterizing the exposome in relation to Alzheimer's disease is innovative, similar studies have shown promise in understanding environmental impacts on health outcomes.

Where this research is happening

Seattle, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAlzheimer's disease and related dementiaAlzheimer's disease and related disorders
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.